BioBrit — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Abintus Bioabintusbio.comAug 2022

BiotechSan Diego, US

Douglas J. Jolly(Founder)inCarlos E. Ibanez(Executive Officer)Robert Anthony Williamson(Director)Troy Wilson(Director)Michael Martin(Director)Nicholas A. Boyle, Ph.D.(Executive Officer, Director)

Co-investorsTakeda Ventures

CRISPR QCcrisprqc.com inMar 2022

CRISPR QC develops the CRISPR Analytics Platform, a graphene-based biosensor system that provides real-time quantitative kinetic measurements of RNP formation, DNA target binding, and CRISPR-Cas cleavage activity.

BiotechDeep TechHardwareSan Diego, US

Ross Bundy(Executive Officer, Director)inKiana Aran(Director)Michael Heltzen(Director)

BoardGeorge Bonaros(Director)Paul Grint(Director)Toby Richardson(Director)

Co-investorsSerra Ventures Suncoast Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.